UBS AM’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.44K | Sell |
1,175
-3,468,165
| -100% | -$18.1M | ﹤0.01% | 3449 |
|
|
2025
Q4 | $17.3M | Buy |
3,469,340
+3,467,672
| +207,894% | +$18.1M | ﹤0.01% | 899 |
|
|
2025
Q3 | $8.46K | Sell |
1,668
-592,937
| -100% | -$2.61M | ﹤0.01% | 2263 |
|
|
2025
Q2 | $2.56M | Sell |
594,605
-3,492,243
| -85% | -$17.3M | ﹤0.01% | 2038 |
|
|
2025
Q1 | $24.6M | Buy |
4,086,848
+410,374
| +11% | +$2.07M | 0.01% | 876 |
|
|
2024
Q4 | $14.5M | Buy |
3,676,474
+150,760
| +4% | +$675K | ﹤0.01% | 1083 |
|
|
2024
Q3 | $20.6M | Buy |
3,525,714
+2,748,245
| +353% | +$13.5M | 0.01% | 939 |
|
|
2024
Q2 | $3.35M | Sell |
777,469
-2,763,067
| -78% | -$13.2M | ﹤0.01% | 1719 |
|
|
2024
Q1 | $16.6M | Buy |
3,540,536
+491,079
| +16% | +$1.88M | 0.01% | 849 |
|
|
2023
Q4 | $15M | Sell |
3,049,457
-31,202
| -1% | -$153K | 0.01% | 853 |
|
|
2023
Q3 | $16.8M | Sell |
3,080,659
-609,565
| -17% | -$4.88M | 0.01% | 802 |
|
|
2023
Q2 | $30.3M | Hold |
3,690,224
| – | – | 0.01% | 680 |
|
|
2023
Q1 | $30.3M | Buy |
3,690,224
+54,716
| +2% | +$604K | 0.01% | 680 |
|
|
2022
Q4 | $40.5M | Buy |
3,635,508
+122,565
| +3% | +$1.42M | 0.02% | 602 |
|
|
2022
Q3 | $41.7M | Sell |
3,512,943
-236,930
| -6% | -$3.59M | 0.02% | 600 |
|
|
2022
Q2 | $57.3M | Sell |
3,749,873
-200,863
| -5% | -$3.61M | 0.03% | 518 |
|
|
2022
Q1 | $83.5M | Buy |
3,950,736
+88,317
| +2% | +$1.9M | 0.04% | 486 |
|
|
2021
Q4 | $91.3M | Buy |
3,862,419
+272,019
| +8% | +$5.83M | 0.03% | 496 |
|
|
2021
Q3 | $72.1M | Buy |
3,590,400
+178,492
| +5% | +$3.66M | 0.03% | 537 |
|
|
2021
Q2 | $68.6M | Sell |
3,411,908
-129,846
| -4% | -$2.78M | 0.03% | 555 |
|
|
2021
Q1 | $75.4M | Buy |
3,541,754
+266,468
| +8% | +$5.73M | 0.03% | 497 |
|
|
2020
Q4 | $71.4M | Buy |
3,275,286
+410,217
| +14% | +$7.99M | 0.03% | 488 |
|
|
2020
Q3 | $50.5M | Buy |
2,865,069
+169,143
| +6% | +$3.15M | 0.03% | 527 |
|
|
2020
Q2 | $50.7M | Sell |
2,695,926
-793,830
| -23% | -$14.1M | 0.03% | 479 |
|
|
2020
Q1 | $60.3M | Sell |
3,489,756
-159,306
| -4% | -$3.33M | 0.04% | 397 |
|
|
2019
Q4 | $77M | Buy |
3,649,062
+2,006,136
| +122% | +$40.6M | 0.05% | 410 |
|
|
2019
Q3 | $32.1M | Buy |
1,642,926
+318,564
| +24% | +$5.85M | 0.02% | 645 |
|
|
2019
Q2 | $23.1M | Sell |
1,324,362
-18,746
| -1% | -$338K | 0.02% | 725 |
|
|
2019
Q1 | $24.9M | Buy |
1,343,108
+153,644
| +13% | +$2.74M | 0.02% | 690 |
|
|
2018
Q4 | $19.1M | Buy |
1,189,464
+3,954
| +0.3% | +$62.5K | 0.02% | 714 |
|
|
2018
Q3 | $17.7M | Buy |
1,185,510
+38,560
| +3% | +$562K | 0.01% | 792 |
|
|
2018
Q2 | $16.1M | Buy |
1,146,950
+15,011
| +1% | +$199K | 0.01% | 822 |
|
|
2018
Q1 | $14.7M | Buy |
1,131,939
+208,818
| +23% | +$2.67M | 0.01% | 824 |
|
|
2017
Q4 | $12.7M | Buy |
923,121
+120,916
| +15% | +$1.63M | 0.01% | 858 |
|
|
2017
Q3 | $10.5M | Buy |
802,205
+23,571
| +3% | +$304K | 0.01% | 891 |
|
|
2017
Q2 | $10M | Buy |
778,634
+169,248
| +28% | +$2.25M | 0.01% | 905 |
|
|
2017
Q1 | $7.85M | Buy |
609,386
+150,588
| +33% | +$1.93M | 0.01% | 939 |
|
|
2016
Q4 | $5.64M | Buy |
458,798
+54,835
| +14% | +$710K | 0.01% | 972 |
|
|
2016
Q3 | $5.97M | Buy |
403,963
+11,413
| +3% | +$173K | 0.01% | 987 |
|
|
2016
Q2 | $5.97M | Buy |
392,550
+32,109
| +9% | +$454K | 0.01% | 976 |
|
|
2016
Q1 | $4.68M | Sell |
360,441
-113,910
| -24% | -$1.3M | 0.01% | 1037 |
|
|
2015
Q4 | $5.46M | Buy |
474,351
+43,279
| +10% | +$494K | 0.01% | 1038 |
|
|
2015
Q3 | $4.77M | Buy |
431,072
+104,355
| +32% | +$1.29M | 0.01% | 1066 |
|
|
2015
Q2 | $4.28M | Buy |
326,717
+244,322
| +297% | +$3.41M | ﹤0.01% | 1107 |
|
|
2015
Q1 | $1.22M | Buy |
82,395
+26,700
| +48% | +$397K | ﹤0.01% | 1559 |
|
|
2014
Q4 | $767K | Buy |
55,695
+4,000
| +8% | +$53.6K | ﹤0.01% | 1711 |
|
|
2014
Q3 | $634K | Sell |
51,695
-175,132
| -77% | -$2.33M | ﹤0.01% | 1747 |
|
|
2014
Q2 | $3M | Buy |
226,827
+16,900
| +8% | +$224K | ﹤0.01% | 1183 |
|
|
2014
Q1 | $2.69M | Buy |
209,927
+2,577
| +1% | +$33.1K | ﹤0.01% | 1209 |
|
|
2013
Q4 | $2.53M | Buy |
207,350
+4,700
| +2% | +$60K | ﹤0.01% | 1184 |
|
|
2013
Q3 | $2.47M | Sell |
202,650
-2,348
| -1% | -$31.4K | ﹤0.01% | 1177 |
|
|
2013
Q2 | $2.94M | Buy |
+204,998
| New | +$3.23M | ﹤0.01% | 1090 |
|
Other funds holding MPT
VPM
VCM
WAM
UBS AM's MPT Position: Q1 2026 in Review
UBS AM reduced its Medical Properties Trust (MPT) stake by 100% in Q1 2026, selling an estimated $18.1M and leaving 1,175 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.
UBS AM first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.3M in Q4 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- UBS AM held 1,175 shares of Medical Properties Trust worth $5.44K as of Q1 2026.
- UBS AM sold 3,468,165 Medical Properties Trust shares in Q1 2026, an estimated $18.1M.
- Medical Properties Trust made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #3449 holding.
- UBS AM first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
- UBS AM's Medical Properties Trust position peaked at $91.3M in Q4 2021.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.